Cargando…
Multiorgan ECV as measured by EQ-MRI in systemic amyloidosis
Autores principales: | Banypersad, Sanjay M, Bandula, Steve, Sado, Daniel, Pinney, Jennifer H, Gibbs, Simon D, Maestrini, Viviana, Fontana, Marianna, White, Steven K, Punwani, Shonit, Taylor, Stuart, Hawkins, Philip N, Moon, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559472/ http://dx.doi.org/10.1186/1532-429X-15-S1-O34 |
Ejemplares similares
-
Native T1 mapping in ATTR cardiac amyloidosis - comparison with AL cardiac amyloidosis - a 200 patient study
por: Fontana, Marianna, et al.
Publicado: (2014) -
AL and ATTR cardiac amyloid are different: native T1 mapping and ECV detect different biology
por: Fontana , Marianna, et al.
Publicado: (2014) -
Cardiac amyloid burden assessment by T1 mapping predicts survival in patients with systemic AL amyloidosis - a 2 year follow-up study
por: Banypersad, Sanjay M, et al.
Publicado: (2014) -
Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR
por: Fontana, Marianna, et al.
Publicado: (2012) -
Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis
por: Karamitsos, Theodoros, et al.
Publicado: (2012)